Detalles de la búsqueda
1.
Younger unrelated donors may be preferable over HLA match in the PTCy era: A study from the ALWP of the EBMT.
Blood
; 2024 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38657278
2.
Posttransplant cyclophosphamide versus anti-thymocyte globulin versus combination for graft-versus-host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party.
Cancer
; 2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38758817
3.
Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation study.
Cancer
; 2024 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38581695
4.
Incidence and outcome of central nervous system relapse after hematopoietic stem cell transplantation in patients suffering from acute myeloid leukemia and acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Haematologica
; 2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38450525
5.
Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Am J Hematol
; 2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38654658
6.
Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1-mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party.
Am J Hematol
; 99(3): 360-369, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38165072
7.
Posttransplant cyclophosphamide versus antithymocyte globulin in patients with acute lymphoblastic leukemia treated with allogeneic hematopoietic cell transplantation from matched unrelated donors: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Cancer
; 129(23): 3735-3745, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37658621
8.
Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission.
Br J Haematol
; 201(6): 1169-1178, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36949658
9.
Fludarabine versus cyclophospamide in combination with myeloablative total body irradiation as conditioning for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Am J Hematol
; 98(4): 580-587, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36626592
10.
Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia.
Cancer
; 128(15): 2922-2931, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35612815
11.
Posttransplant cyclophosphamide-based anti-graft-vs-host disease prophylaxis in patients with acute lymphoblastic leukemia treated in complete remission with allogeneic hematopoietic cell transplantation from human leukocyte antigen-mismatched unrelated donors versus haploidentical donors: A study on behalf of the ALWP of the EBMT.
Cancer
; 128(22): 3959-3968, 2022 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36110063
12.
Human leukocyte antigen-haploidentical transplantation for relapsed/refractory acute myeloid leukemia: Better leukemia-free survival with bone marrow than with peripheral blood stem cells in patients ≥55 years of age.
Am J Hematol
; 97(8): 1065-1074, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35696192
13.
Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3-ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation.
Am J Hematol
; 97(3): 274-282, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34978724
14.
Outcome of T-cell-replete haploidentical stem cell transplantation improves with time in adults with acute lymphoblastic leukemia: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Cancer
; 127(14): 2507-2514, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33739471
15.
Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Cancer
; 127(2): 209-218, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33119152
16.
Second allogeneic haematopoietic cell transplantation using HLA-matched unrelated versus T-cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia.
Br J Haematol
; 193(3): 592-601, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33838047
17.
Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation.
Blood
; 134(11): 892-899, 2019 09 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31270102
18.
Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia.
Haematologica
; 106(6): 1591-1598, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32354866
19.
Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party.
Haematologica
; 106(2): 375-383, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31949011
20.
The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP) of the European group for blood and marrow transplantation (EBMT).
Am J Hematol
; 96(1): 40-50, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32944990